BPN14770 Single Ascending Dose Study in Healthy Male and Female Subjects

Summary

This is a randomized double-blind (investigator and subject blinded), placebo controlled ascending single dose study to evaluate the safety, tolerability, and pharmacokinetic profile of BPN14770 in healthy male and female subjects. Each subject will be randomized to receive either a single dose of BPN14770 or placebo.

Timeline

Start

2015-12

Primary completion

2016-02

Completion

2016-07

Drugs

Indications